Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Ipca Laboratories Limited

Market Cap 39TCr 412.9Cr 355.83Cr 327.67Cr 307.65Cr 577.61Cr 583.71Cr 3.87TCr 1.51TCr 19TCr 1.55TCr 1.52TCr 66TCr P/E 2026
35.6x
P/E 2027 * 28.2x
Enterprise Value 39TCr 407.59Cr 351.26Cr 323.46Cr 303.7Cr 570.19Cr 576.21Cr 3.82TCr 1.49TCr 19TCr 1.53TCr 1.5TCr 65TCr EV / Sales 2026
4.24x
EV / Sales 2027 * 3.46x
Free-Float
54.92%
Yield 2026
0.37%
Yield 2027 * 0.37%
1 day-0.80%
1 week-5.87%
Current month+1.68%
1 month-6.56%
3 months-1.85%
6 months+10.14%
Current year+8.02%
1 week 1,532.1
Extreme 1532.1
1,640.95
1 month 1,470.6
Extreme 1470.6
1,679.45
Current year 1,392
Extreme 1392
1,679.45
1 year 1,252.95
Extreme 1252.95
1,679.45
3 years 692.3
Extreme 692.3
1,757.65
5 years 670
Extreme 670
1,757.65
10 years 200
Extreme 200
1,757.65
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%-5.87% - - 415.98Cr
-0.52%-1.80%+41.03%+146.91% 1,00100Cr
-0.75%-2.57%+52.48%+41.56% 57TCr
-0.55%-1.92%+18.95%+60.09% 39TCr
+0.46%+2.29%+24.04%+16.53% 33TCr
+0.89%+1.18%+26.02%+32.57% 28TCr
+0.81%-0.62%+25.49%+14.89% 28TCr
+1.88%+1.32%-41.22%-47.02% 19TCr
-0.03%+3.17%+20.13%+52.43% 19TCr
-0.11%+4.56%+17.61%+63.46% 16TCr
Average +0.11%+0.35%+20.50%+42.38% 37.52TCr
Weighted average by Cap. -0.08%-0.41%+29.29%+66.19%

Financials

2026 2027 *
Net sales 9.66TCr 102.19Cr 88Cr 81Cr 76Cr 142.96Cr 144.47Cr 958.27Cr 373.32Cr 4.73TCr 383.51Cr 375.36Cr 16TCr 11TCr 113.93Cr 98Cr 90Cr 85Cr 159.38Cr 161.06Cr 1.07TCr 416.21Cr 5.27TCr 427.57Cr 418.48Cr 18TCr
Net income 1.12TCr 12Cr 10Cr 9.41Cr 8.83Cr 17Cr 17Cr 111.16Cr 43Cr 548.84Cr 44Cr 44Cr 1.9TCr 1.4TCr 15Cr 13Cr 12Cr 11Cr 21Cr 21Cr 139.22Cr 54Cr 687.39Cr 56Cr 55Cr 2.38TCr
Net Debt -501.7Cr -5.31Cr -4.57Cr -4.21Cr -3.95Cr -7.42Cr -7.5Cr -50Cr -19Cr -245.68Cr -20Cr -19Cr -851.42Cr -1.72TCr -18Cr -16Cr -14Cr -14Cr -25Cr -26Cr -170.29Cr -66Cr -840.77Cr -68Cr -67Cr -2.91TCr
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
16,778
Date Price Change Volume
17/26/17 1,538.25 -0.80% 6,055
16/26/16 1,550.70 -1.60% 35,980
15/26/15 1,575.90 -0.62% 47,915
12/26/12 1,585.80 -1.69% 4,010
11/26/11 1,613.05 -1.30% 2,13,118
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,550.20INR
Average target price
1,719.61INR
Spread / Average Target
+10.93%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!